Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,077 | 0,084 | 12:53 | |
0,077 | 0,084 | 12:33 |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
18.04. | DOTZ NANO LIMITED: Change of Auditor | - | ASX | ||
07.04. | DOTZ NANO LIMITED: Date of AGM and Director Nominations | - | ASX | ||
25.03. | DOTZ NANO LIMITED: Investor Presentation | 1 | ASX | ||
24.03. | DOTZ NANO LIMITED: Initial Director's Interest Notice - S Malka | - | ASX | ||
20.03. | Dotz Nano: Advancing towards a carbon neutral future | 1 | Finance News Network | ||
19.03. | DOTZ NANO LIMITED: Dotz receives additional $3m under funding agreement | - | ASX | ||
19.03. | DOTZ NANO LIMITED: Cleansing Notice - Convertible Notes | - | ASX | ||
19.03. | DOTZ NANO LIMITED: Notification regarding unquoted securities - DTZ | - | ASX | ||
19.03. | DOTZ NANO LIMITED: Notification regarding unquoted securities - DTZ | - | ASX | ||
19.03. | DOTZ NANO LIMITED: Application for quotation of securities - DTZ | 1 | ASX | ||
19.03. | DOTZ NANO LIMITED: Cleansing Notice | 1 | ASX | ||
14.03. | DOTZ NANO LIMITED: Application for quotation of securities - DTZ | 1 | ASX | ||
14.03. | DOTZ NANO LIMITED: Cleansing Statement | 1 | ASX | ||
12.03. | DOTZ NANO LIMITED: Results of Meeting | 1 | ASX | ||
07.03. | Driving carbon neutrality: Dotz Nano's breakthrough in CO2 Management | 2 | Finance News Network | ||
07.03. | Dotz Nano advances climate solutions with 'Dotz Earth' | 1 | The Market Herald Australia | ||
07.03. | Stocks of the Hour: Dotz Nano, Immuron, Avecho Biotechnology | 7 | Finance News Network | ||
05.03. | DOTZ NANO LIMITED: Dotz achieves technology milestone for CO2 Capture | - | ASX | ||
05.03. | DOTZ NANO LIMITED: Initial Director's Interest Notice - G Kelly | 1 | ASX | ||
28.02. | DOTZ NANO LIMITED: FY23 Results Announcement | - | ASX |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 39,750 | 0,00 % | Übernahme-Gerüchte bei BioTech-Aktien: BioNTech, Formycon, Cardiol Therapeutics und Novo Nordisk im Fokus | Der BioTech-Sektor ist im laufenden Jahr hinter der Performance von Künstlicher Intelligenz und Hightech deutlich zurückbleiben. Das liegt an der hohen Teuerung, die ihrerseits eine baldige Zinssenkung... ► Artikel lesen | |
KOPIN | 0,811 | +1,25 % | Kopin Says Jury Awards Damages Of About $24.8 Mln To BlueRadios | WASHINGTON (dpa-AFX) - Kopin Corp., Inc. (KOPN) announced Tuesday that a jury verdict was entered on Monday in the U.S. District Court for the District of Colorado finding for the plaintiff... ► Artikel lesen | |
ONTO INNOVATION | 168,00 | +1,20 % | Onto Innovation (ONTO) Adds New Capability to Dragonfly System | ||
LEHNER INVESTMENTS | 0,055 | +71,88 % | EQS-News: LEHNER INVESTMENTS AG - Neuer Vorstand, Wechsel im Aufsichtsrat | EQS-News: LEHNER INVESTMENTS AG
/ Schlagwort(e): Personalie
LEHNER INVESTMENTS AG - Neuer Vorstand, Wechsel im Aufsichtsrat
24.04.2024 / 11:24 CET/CEST
Für den Inhalt... ► Artikel lesen | |
ACACIA RESEARCH | 4,520 | 0,00 % | Acacia Research Reports Fourth Quarter 2023 Financial Results | NEW YORK--(BUSINESS WIRE)--Acacia Research Corporation (Nasdaq: ACTG) ("Acacia" or the "Company") today reported financial results for the three months and full year ended December 31, 2023.
Martin... ► Artikel lesen | |
ADVANCE ZINCTEK | 0,505 | -1,94 % | ADVANCE ZINCTEK LIMITED: US Sales | ||
NANOFOCUS | 0,400 | 0,00 % | Nanofocus: Investor verlängert die Frist | Die Carl Mahr Holding hat im März ein freiwilliges öffentliches Erwerbsangebot für die Aktien von Nanofocus abgegeben. Geboten werden dabei 0,50 Euro je Aktie von Nanofocus. Ursprünglich konnten Investoren... ► Artikel lesen | |
RIBER | 2,730 | +1,49 % | RIBER: Strong growth in 2023 full-year earnings | Strong growth in 2023 full-year earnings Revenues: €39.3m (+41%) driven by the robust development of systems (+96%)Operating income: €3.9m, representing 10% of revenuesNet income: €3.4m, representing... ► Artikel lesen | |
NANOVIRICIDES | 1,040 | -0,95 % | NanoViricides, Inc.: NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon | SHELTON, CT / ACCESSWIRE / February 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly... ► Artikel lesen | |
ZENTEK | 1,060 | +3,92 % | Zentek Ltd.: Zentek Announces U.S. Distribution Agreement for ZenGUARDTM-Enhanced Surgical Masks with Medwell Solutions | GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce... ► Artikel lesen | |
GOMSPACE | 0,342 | 0,00 % | GomSpace A/S: GomSpace receives order for cutting-edge products from diverse customers at a total value of €923.000 (approx. 10.8MSEK) | STOCKHOLM, Oct. 31, 2023 /PRNewswire/ -- GomSpace gives an update on its product business and announces that the company has received, since the last press release on September 21, new product... ► Artikel lesen | |
REGION GROUP | 1,298 | 0,00 % | REGION GROUP: Change in substantial holding | ||
XTPL | 31,800 | -5,07 % | EQS-News: XTPL S.A.: XTPL liefert weiteres Industriemodul an HB Technology | Emittent / Herausgeber: XTPL S.A.
/ Schlagwort(e): Vereinbarung
XTPL liefert weiteres Industriemodul an HB Technology
18.04.2024 / 09:15 CET/CEST
Für den Inhalt der... ► Artikel lesen | |
NANOFORM FINLAND | 2,160 | -16,28 % | Nanoform successfully completes new share issue raising EUR 15.4 million to invest in commercialization of nanoparticle enabled formulations for next generation medicines | ||
INSPLORION | 0,200 | +21,58 % | Nasdaq Stockholm AB: New equity rights for trading, Insplorion AB (publ) (625/23) | At the request of Insplorion AB (publ), equity rights will be traded on First
North as from December 5, 2023.
Security name: Insplorion AB TO2
Short name: INSP TO2
ISIN code: SE0020999175... ► Artikel lesen |